Skip to main content
NVST logo

Envista Holdings Corporation

NVSTNYSEHealthcareMedical Instruments & Supplies

$22.90Today:- (-)1Y +17.74%

As of Oct 16, 2026 close

Market cap
$3.86B
P/E (TTM)
23.51
Forward P/E
11.87
Dividend yield
-
52-week range
$18.77$30.42
Volume (live)
-
Avg. volume (3M)
2.84M

Envista Holdings (NVST) Stock Price & Financial Analysis

Envista Holdings Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$22.81 - $23.67
52-Week High$30.42
52-Week Low$18.77
Open$23.50
Volume (last close)2.32M
Average Volume (3M)2.84M
Earnings & Profitability
Revenue (TTM)2.87B
Net Income (TTM)164.00M
Free Cash Flow (TTM)177.00M
EPS (TTM)$0.99
Profit Margin5.71%
Operating Margin10.39%
Return on Equity (ROE)5.33%
Debt to Equity0.47
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Size & Valuation
Market Cap3.86B
Shares Outstanding164.10M
P/E Ratio (TTM)23.51
Forward P/E11.87
Price to Sales (P/S)1.34
Price to Book (P/B)1.25
EV/EBITDA10.27
Technical Indicators
50-Day MA$25.67
200-Day MA$25.70
1-Year Change+17.74%

Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology

Compare NVST with other stocks

Envista Holdings at a Glance

As of the Oct 16, 2026 close, Envista Holdings (NVST) has a market capitalization of $3.86B. The stock trades at 23.5× trailing earnings, 11.9× forward earnings and 1.3× sales. Over the trailing twelve months it earned $164.00M on revenue of $2.87B (a 5.7% profit margin) and generated $177.00M of free cash flow. Revenue grew 5.6% year over year.

As of its latest reported balance sheet, it holds $1.13B in cash and securities against $1.44B of debt, a net debt position of $313.50M.

Envista Holdings does not currently pay a dividend.

The share price is up 17.7% over the past year. At $22.90 (the Oct 16, 2026 close) it sits within its 52-week range of $18.77 to $30.42, below its 200-day moving average of $25.70.

Based on 20 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $30.23, 32.0% above the Oct 16, 2026 close.

Frequently Asked Questions About Envista Holdings

What is the current stock price for NVST?

As of the Oct 16, 2026 close, NVST stock trades at $22.90. The 52-week range is $18.77–$30.42, with a day range of $22.81–$23.67.

What is the P/E ratio for NVST?

As of the Oct 16, 2026 close, Envista Holdings's trailing twelve-month (TTM) P/E ratio is 23.5, meaning investors pay $23.5 for every $1 of annual earnings. The forward P/E is 11.9, reflecting analyst expectations for future earnings. Envista Holdings operates in the Healthcare sector.

Does NVST pay dividends?

Envista Holdings does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.

What do analysts recommend for NVST?

Based on ratings from 20 professional analysts over the last 90 days, the consensus for NVST is Buy. The average 12-month price target is $30.23, a 32.0% upside from the Oct 16, 2026 close of $22.90.

What is the market cap of NVST?

As of the Oct 16, 2026 close, Envista Holdings's market capitalization is $3.76B, classifying it as a mid-cap company. Envista Holdings operates in the Healthcare sector within the Medical Instruments & Supplies industry.